Short answer
ZEVRA THERAPEUTICS, INC. (ZVRA) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results and corporate updates announced for quarter ended March 31, 2026.
ZEVRA THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results and corporate updates announced for quarter ended March 31, 2026
- Conference call and webcast scheduled May 6, 2026, at 4:30 p.m. ET
- Press release furnished as Exhibit 99.1, where detailed financial figures and operational updates are provided
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ZEVRA THERAPEUTICS, INC. 8-K filings
Get the next ZVRA 8-K as it lands
Follow ZVRA for push alerts, or ask the research agent what this filing means.